On December 9, 2008 Chile’s antitrust authority, the Fiscalía Nacional Económica (FNE), filed a complaint with the Tribunal de Defensa de la Libre Competencia (TDLC) against three major pharmacy chains for fixing the prices of more than 200 drugs since December 2007. Some of the prices allegedly fixed by defendants Ahumada (FASA), Cruz Verde and Salcobrand included contraceptives and medicines to treat chronic diseases such as diabetes and epilepsy. In 2007 Ahumada, Cruz Verde and Salcobrand held market shares for the retail sale of drugs of 27.7 percent, 40.6 percent and 23.8 percent, respectively. The FNE is seeking the maximum fine, or US$13.4 million, for each company.